Eleonora Baldi

1.2k total citations
36 papers, 853 citations indexed

About

Eleonora Baldi is a scholar working on Pathology and Forensic Medicine, Oncology and Immunology. According to data from OpenAlex, Eleonora Baldi has authored 36 papers receiving a total of 853 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pathology and Forensic Medicine, 11 papers in Oncology and 8 papers in Immunology. Recurrent topics in Eleonora Baldi's work include Multiple Sclerosis Research Studies (17 papers), Polyomavirus and related diseases (5 papers) and Colorectal Cancer Surgical Treatments (4 papers). Eleonora Baldi is often cited by papers focused on Multiple Sclerosis Research Studies (17 papers), Polyomavirus and related diseases (5 papers) and Colorectal Cancer Surgical Treatments (4 papers). Eleonora Baldi collaborates with scholars based in Italy, Germany and Serbia. Eleonora Baldi's co-authors include Massimiliano Castellazzi, Enrico Granieri, Enrico Fainardi, Pierfrancesco Bonfante, Daniela Gianquinto, R Fardelli, Tiziana Bellini, Lorenzo E. Derchi, Giambattista Ravera and Ilaria Casetta and has published in prestigious journals such as International Journal of Molecular Sciences, Journal of the Neurological Sciences and Annals of Surgical Oncology.

In The Last Decade

Eleonora Baldi

35 papers receiving 831 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eleonora Baldi Italy 15 312 279 265 145 90 36 853
Ginette Schiby Israel 18 214 0.7× 220 0.8× 219 0.8× 249 1.7× 76 0.8× 53 883
Martin Krakauer Denmark 23 301 1.0× 619 2.2× 553 2.1× 256 1.8× 89 1.0× 48 1.4k
S Fukuhara Japan 19 250 0.8× 329 1.2× 408 1.5× 358 2.5× 61 0.7× 40 1.3k
Oliver Wengert Germany 8 98 0.3× 148 0.5× 142 0.5× 148 1.0× 58 0.6× 10 501
Akihiro Iguchi Japan 18 219 0.7× 70 0.3× 169 0.6× 173 1.2× 185 2.1× 84 1.0k
Sara Szabo United States 17 327 1.0× 148 0.5× 142 0.5× 208 1.4× 364 4.0× 69 1.0k
Byung Lae Park South Korea 19 122 0.4× 175 0.6× 191 0.7× 367 2.5× 70 0.8× 40 996
Agata Kosmaczewska Poland 19 245 0.8× 128 0.5× 499 1.9× 100 0.7× 32 0.4× 49 785
Boel Brynedal Sweden 17 326 1.0× 301 1.1× 709 2.7× 290 2.0× 150 1.7× 34 1.4k
A Tobler Switzerland 11 225 0.7× 105 0.4× 235 0.9× 216 1.5× 89 1.0× 21 890

Countries citing papers authored by Eleonora Baldi

Since Specialization
Citations

This map shows the geographic impact of Eleonora Baldi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eleonora Baldi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eleonora Baldi more than expected).

Fields of papers citing papers by Eleonora Baldi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eleonora Baldi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eleonora Baldi. The network helps show where Eleonora Baldi may publish in the future.

Co-authorship network of co-authors of Eleonora Baldi

This figure shows the co-authorship network connecting the top 25 collaborators of Eleonora Baldi. A scholar is included among the top collaborators of Eleonora Baldi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eleonora Baldi. Eleonora Baldi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Baldi, Eleonora, et al.. (2025). The Diagnostic Utility of Oligoclonal Bands in Multiple Sclerosis: A Time-Course Analysis. Biomedicines. 13(2). 440–440. 1 indexed citations
2.
Castellazzi, Massimiliano, Elisa Baldin, Eleonora Baldi, et al.. (2023). Gut Microbiota Changes during Dimethyl Fumarate Treatment in Patients with Multiple Sclerosis. International Journal of Molecular Sciences. 24(3). 2720–2720. 14 indexed citations
3.
Castellazzi, Massimiliano, et al.. (2023). Dimethyl Fumarate Treatment Reduces the Amount but Not the Avidity of the Epstein–Barr Virus Capsid-Antigen-Specific Antibody Response in Multiple Sclerosis: A Pilot Study. International Journal of Molecular Sciences. 24(2). 1500–1500. 2 indexed citations
4.
Malaventura, Cristina, V. Tugnoli, Elisabetta Marangoni, et al.. (2023). Pediatric recurrent acute necrotizing encephalomyelitis, RANBP2 genotype and Sars-CoV-2 infection: Diagnosis, pathogenesis and targeted treatments from a case study. European Journal of Paediatric Neurology. 42. 117–121. 10 indexed citations
5.
Bortolotti, Daria, Valentina Gentili, Alessandra Bortoluzzi, et al.. (2022). Herpesvirus Infections in KIR2DL2-Positive Multiple Sclerosis Patients: Mechanisms Triggering Autoimmunity. Microorganisms. 10(3). 494–494. 3 indexed citations
6.
Bortolotti, Daria, Yurou Sang, Giovanna Schiuma, et al.. (2022). Studying the Interactions of U24 from HHV-6 in Order to Further Elucidate Its Potential Role in MS. Viruses. 14(11). 2384–2384. 3 indexed citations
7.
Curti, Erica, Diana Ferraro, Alessandra Lugaresi, et al.. (2020). Dimethyl fumarate‐induced lymphocyte count drop is related to clinical effectiveness in relapsing–remitting multiple sclerosis. European Journal of Neurology. 28(1). 269–277. 1 indexed citations
8.
Castellazzi, Massimiliano, Carmine Tamborino, Eleonora Baldi, et al.. (2020). Increased age and male sex are independently associated with higher frequency of blood–cerebrospinal fluid barrier dysfunction using the albumin quotient. Fluids and Barriers of the CNS. 17(1). 14–14. 49 indexed citations
9.
Curti, Erica, Eleonora Baldi, Luisa Caniatti, et al.. (2019). The real-world effectiveness of natalizumab and fingolimod in relapsing-remitting multiple sclerosis. An Italian multicentre study. Multiple Sclerosis and Related Disorders. 33. 146–152. 13 indexed citations
10.
Granieri, Enrico, Vittorio Govoni, Massimiliano Castellazzi, et al.. (2018). Multiple Sclerosis in Italy: A 40-Year Follow-Up of the Prevalence in Ferrara. Neuroepidemiology. 51(3-4). 158–165. 7 indexed citations
11.
Trentini, Alessandro, Massimiliano Castellazzi, Arianna Romani, et al.. (2017). Evaluation of total, ceruloplasmin-associated and type II ferroxidase activities in serum and cerebrospinal fluid of multiple sclerosis patients. Journal of the Neurological Sciences. 377. 133–136. 8 indexed citations
12.
Trentini, Alessandro, Massimiliano Castellazzi, Carlo Cervellati, et al.. (2016). Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients. Disease Markers. 2016. 1–9. 24 indexed citations
13.
Rizzo, Roberta, Daria Bortolotti, Enrico Fainardi, et al.. (2016). KIR2DL2 inhibitory pathway enhances Th17 cytokine secretion by NK cells in response to herpesvirus infection in multiple sclerosis patients. Journal of Neuroimmunology. 294. 1–5. 17 indexed citations
14.
Castellazzi, Massimiliano, Carlo Contini, Carmine Tamborino, et al.. (2014). Epstein-Barr virus-specific intrathecal oligoclonal IgG production in relapsing-remitting multiple sclerosis is limited to a subset of patients and is composed of low-affinity antibodies. Journal of Neuroinflammation. 11(1). 188–188. 36 indexed citations
15.
Morandi, Fabio, Consuelo Venturi, Roberta Rizzo, et al.. (2013). Intrathecal Soluble HLA-E Correlates with Disease Activity in Patients with Multiple Sclerosis and may Cooperate with Soluble HLA-G in the Resolution of Neuroinflammation. Journal of Neuroimmune Pharmacology. 8(4). 944–955. 32 indexed citations
16.
Rizzo, Roberta, Daria Bortolotti, Nadia Ben Fredj, et al.. (2012). Role of HLA-G 14bp deletion/insertion and +3142C>G polymorphisms in the production of sHLA-G molecules in relapsing-remitting multiple sclerosis. Human Immunology. 73(11). 1140–1146. 50 indexed citations
17.
Bardazzi, Federico, et al.. (2010). Correlation between BMI and PASI in patients affected by moderate to severe psoriasis undergoing biological therapy. Dermatologic Therapy. 23. S14–S19. 87 indexed citations
18.
Fardelli, R, Daniela Gianquinto, Pierfrancesco Bonfante, et al.. (2002). Efficacy and cost of risk-adapted follow-up in patients after colorectal cancer surgery: a prospective, randomized and controlled trial. European Journal of Surgical Oncology. 28(4). 418–423. 160 indexed citations
19.
Fardelli, R, et al.. (2000). Is Intensive Follow-Up Really Able to Improve Prognosis of Patients With Local Recurrence After Curative Surgery for Rectal Cancer?. Annals of Surgical Oncology. 7(1). 32–37. 32 indexed citations
20.
Fardelli, R, et al.. (1999). Local Control after Curative Surgery for Cancer of the Extraperitoneal Rectum. Oncology. 56(3). 193–197. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ginette Schiby Breakdown of academic impact, for papers by Martin Krakauer Breakdown of academic impact, for papers by S Fukuhara Breakdown of academic impact, for papers by Oliver Wengert Breakdown of academic impact, for papers by Akihiro Iguchi Breakdown of academic impact, for papers by Sara Szabo Breakdown of academic impact, for papers by Byung Lae Park Breakdown of academic impact, for papers by Agata Kosmaczewska Breakdown of academic impact, for papers by Boel Brynedal Breakdown of academic impact, for papers by A Tobler
Rankless by CCL
2026